FENGYUAN(SZ:002805)2025-04-28 11:20Revenue and Profitability - The company's revenue for Q1 2025 reached ¥367,266,847.86, representing a 109.52% increase compared to ¥175,288,013.83 in the same period last year[4] - The net loss attributable to shareholders was ¥89,884,022.55, worsening from a loss of ¥39,119,239.27 in the previous year[4] - The net loss for the current period was ¥109,373,496.62, compared to a net loss of ¥52,657,320.36 in the previous period, indicating a deterioration in profitability[18] Cash Flow and Financial Position - The net cash flow from operating activities was negative at ¥9,303,594.56, a decline of 105.07% from a positive cash flow of ¥183,521,590.99 in the same period last year[7] - Cash and cash equivalents at the end of the period decreased to ¥105,367,161.30 from ¥629,174,720.41, reflecting a reduction of approximately 83.2%[20] - The company raised ¥53,810,000.00 through borrowings during the current period, compared to no borrowings in the previous period, indicating a shift in financing strategy[20] Assets and Liabilities - Total assets increased by 1.40% to ¥5,515,747,123.50 from ¥5,439,537,400.30 at the end of the previous year[4] - Total current liabilities rose to ¥2,450,480,392.65 from ¥2,241,579,732.82, an increase of about 9.3%[14] - Total liabilities increased to ¥3,302,894,884.33 from ¥3,117,583,328.61, reflecting a growth of approximately 5.9%[14] - The company's equity remained stable with total equity at ¥2,212,852,239.17, unchanged from the previous period[14] Current Assets and Expenses - Accounts receivable increased by 149.66% to ¥98,023,847.83 due to an increase in bill endorsement settlement volume[6] - Prepayments surged by 240.57% to ¥101,364,608.94, attributed to increased advance payments for raw materials[6] - The company reported a significant increase in other current liabilities, which rose by 349.98% to ¥95,832,780.44, due to bank bills used for raw material procurement[6] - The financial expenses increased by 97.70% to ¥26,931,887.09, primarily due to higher interest expenses on bank loans[7] - Research and development expenses increased to ¥5,471,788.61 from ¥4,238,854.22, showing a growth of about 29.2%[17] Inventory and Operating Costs - Inventory rose to ¥539,143,799.30 from ¥478,632,159.35, indicating an increase of approximately 12.7%[13] - Total operating costs increased to ¥479,222,557.58 from ¥246,843,312.27, marking a rise of about 94.3%[17] Reporting and Compliance - The first quarter report is unaudited[21] - The new accounting standards will be implemented starting in 2025[21] - The financial statement adjustments related to the first year of implementation will be disclosed[21] - The board of directors of Shandong Fengyuan Chemical Co., Ltd. issued the report on April 28, 2025[21]